The American Society of Hematology elected four new members to its executive committee for terms beginning after the 2022 ASH Annual Meeting, Dec. 10-13 in New Orleans.
Kite announced findings from three new analyses for Yescarta (axicabtagene ciloleucel) that demonstrate improved outcomes for people living with relapsed or refractory large B-cell lymphoma, which were presented at 66th American Society of Hematology annual meeting.
